# N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy

Study · id `cardio:ct-nct01265563` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01265563](<https://clinicaltrials.gov/study/NCT01265563>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01265563

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.

## Technical summary

Registry record NCT01265563. Randomized; triple masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2015-02 (actual). Results posted on 2017-03-31.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 108 participants (enrolled count; ClinicalTrials.gov record NCT01265563, source copy `cardio:ctgov-nct01265563-2018-10-19`, retrieved 2026-10-26)
- Start date: 2011-01 (registry gives no type) (ClinicalTrials.gov record NCT01265563, source copy `cardio:ctgov-nct01265563-2018-10-19`, retrieved 2026-10-26)
- Primary completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01265563, source copy `cardio:ctgov-nct01265563-2018-10-19`, retrieved 2026-10-26)
- Completion: 2016-12 (actual) (ClinicalTrials.gov record NCT01265563, source copy `cardio:ctgov-nct01265563-2018-10-19`, retrieved 2026-10-26)
- Results first posted: 2017-03-31 (ClinicalTrials.gov record NCT01265563, source copy `cardio:ctgov-nct01265563-2018-10-19`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01265563, source copy `cardio:ctgov-nct01265563-2018-10-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01265563-2018-10-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
- Acronym: CGDN
- Condition: Diabetic Nephropathy
- Condition: Proteinuria
- Condition: Oxidative Stress
- Intervention (Drug): N-acetylcysteine placebo and silibin placebo
- Intervention (Drug): N-acetylcysteine active and silibin placebo
- Intervention (Drug): N-acetylcysteine placebo and silibin active
- Intervention (Drug): N-acetylcysteine active and silibin active
- Intervention (Drug): N-acetylcysteine active + high-dose silibin active
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED
- Collaborator: National Center for Complementary and Integrative Health (NCCIH)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)
- Registry lists this organization as a collaborator: National Center for Complementary and Integrative Health (NCCIH) (`cardio:org-national-center-for-complementary-and-integrative-health-04ced1`)

## Provenance

Content hash: cedd7f98fc97b1851c8829538db7b3da7c4ab2e71e715c47fe1b152bce13fe20
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
